Bronchial asthma is a disease that seriously harms the health of children in China. The full text summarizes the current treatment of bronchial asthma in children at home and abroad, analyzes the advantages and disadvantages of first-line treatment drugs, and introduces new drug treatment methods at home and abroad, especially the application of monoclonal antibodies in new biological preparations, which provides a basis for clinical treatment of bronchial asthma in children.%支气管哮喘是严重危害我国儿童健康的疾病.全文就目前国内外儿童支气管哮喘治疗药物进行综述,分析一线治疗药物的优势和不足,同时介绍国内外新型药物治疗方法,特别是新型生物制剂单克隆抗体的应用.为儿童支气管哮喘的临床治疗提供依据.
展开▼
